Dlaboratory Sweden AB (publ) (STO:DLAB)
Sweden · Delayed Price · Currency is SEK 2.300
0.00 (0.00%)
Jul 20, 2026, 5:24 PM CET
Dlaboratory Sweden AB Revenue
Dlaboratory Sweden AB had revenue of 3.82M SEK in the quarter ending March 31, 2026, with 55.53% growth. This brings the company's revenue in the last twelve months to 42.81M, down -1.69% year-over-year. In the year 2025, Dlaboratory Sweden AB had annual revenue of 46.40M, down -4.58%.
Revenue (ttm)
42.81M
Revenue Growth
-1.69%
P/S Ratio
0.91
Revenue / Employee
1.58M
Employees
27
Market Cap
38.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 46.40M | -2.23M | -4.58% |
| Dec 31, 2024 | 48.63M | 3.26M | 7.19% |
| Dec 31, 2023 | 45.36M | -2.14M | -4.51% |
| Dec 31, 2022 | 47.51M | 28.93M | 155.73% |
| Dec 31, 2021 | 18.58M | 13.48M | 264.11% |
| Dec 31, 2020 | 5.10M | -2.56M | -33.45% |
| Dec 31, 2019 | 7.67M | 2.43M | 46.44% |
| Dec 31, 2018 | 5.24M | -1.34M | -20.36% |
| Dec 31, 2017 | 6.57M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fragbite Group AB | 111.64M |
| LifeClean International AB | 47.87M |
| Sonetel AB | 32.64M |
| Aino Health AB | 24.27M |
| Fluicell AB | 20.15M |
| Zaplox AB | 18.44M |
| XMReality AB | 18.21M |
| ExpreS2ion Biotech Holding AB | 16.12M |
Dlaboratory Sweden AB News
- 2 months ago - Dlaboratory Sweden AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Dlaboratory Sweden AB Annual report: Q4 2025 - Filings
- 5 months ago - Dlaboratory Sweden AB Quarterly report: Q4 2025 - Filings
- 8 months ago - Dlaboratory Sweden AB Quarterly report: Q3 2025 - Filings
- 11 months ago - Dlaboratory Sweden AB Quarterly report: Q2 2025 - Filings